Demographics and Pathogenesis of Plaque Psoriasis

Author(s):

Brad Glick, DO, MPH,Mona Shahriari, MD, FAAD

Brad Glick, MD; Mona Shahriari, MD, FAAD; Michael Cameron, MD, FAAD; and Linda Stein Gold, MD, provide an overview of plaque psoriasis, highlighting demographics and risk factors, as well as the pathophysiology of the disease.

Now Viewing

EP: 1.Demographics and Pathogenesis of Plaque Psoriasis

EP: 2.Disease Burden of Plaque Psoriasis

EP: 3.Current Treatment Options in Plaque Psoriasis

Demographics and Pathogenesis of Plaque Psoriasis

EP: 1.Demographics and Pathogenesis of Plaque Psoriasis

EP: 2.Disease Burden of Plaque Psoriasis

EP: 3.Current Treatment Options in Plaque Psoriasis

EP: 4.Standard of Care for Patients With Plaque Psoriasis

EP: 5.Treatment Selection for Patients With Plaque Psoriasis

EP: 6.Managing Plaque Psoriasis in Difficult-to-Treat Areas

EP: 7.Remittive and Suppressive Therapy in Plaque Psoriasis

EP: 8.Use of Topical Therapy in Mild-to-Moderate Plaque Psoriasis

EP: 9.Emerging Treatment in Plaque Psoriasis

EP: 10.Long-Term Study Data of Tapinarof in Plaque Psoriasis

EP: 11.Clinical Trials of Roflumilast in Plaque Psoriasis

EP: 12.The Impact of Non-Steroidal Topical Agents in Plaque Psoriasis

EP: 13.The Future of Plaque Psoriasis Treatment